Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Transactions of the Association of American Physicians
|
January 1, 1982
Cultured juxtaglomerular cells cause hypertension by secreting angiotensin
E E Muirhead, W A Rightsel, J A Pitcock, et al.
British Journal of Cancer
|
April 17, 2015
An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patients
W Ichikawa, K Uehara, K Minamimura, et al.
British Journal of Cancer
|
March 15, 2012
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial
I Mochizuki, H Takiuchi, K Ikejiri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2014
S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)
M Yoshida, M Ishiguro, K Ikejiri, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Lymph node mapping-based optimal bowel-resection margin and central radicality in colon cancer surgery: an international, prospective, observational cohort study
H Ueno, N K Kim, J C Kim, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Transactions of the Association of American Physicians
|
January 1, 1982
Cultured juxtaglomerular cells cause hypertension by secreting angiotensin
E E Muirhead, W A Rightsel, J A Pitcock, et al.
British Journal of Cancer
|
April 17, 2015
An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patients
W Ichikawa, K Uehara, K Minamimura, et al.
British Journal of Cancer
|
March 15, 2012
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial
I Mochizuki, H Takiuchi, K Ikejiri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2014
S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)
M Yoshida, M Ishiguro, K Ikejiri, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Lymph node mapping-based optimal bowel-resection margin and central radicality in colon cancer surgery: an international, prospective, observational cohort study
H Ueno, N K Kim, J C Kim, et al.
Page
of 5